May 28, 2020 7:00 am EDT Cerecor Announces FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS
May 26, 2020 7:00 am EDT Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study
Mar 26, 2020 6:30 am EDT Cerecor Announces Exploration of the Role of an Inflammatory Cytokine, LIGHT, in COVID-19 Patients with Acute Lung Injury Leading to Acute Respiratory Distress Syndrome
Mar 6, 2020 9:00 am EST Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer
